Objective This study aims:(a) to evaluate patterns of domperidone dispensing to mothers of
very preterm (< 32 weeks gestation) infants born before and after 2014 when international …

Purpose To examine differences in longer-term breastfeeding outcomes among mothers of
preterm infants according to domperidone exposure status, as well as examine the potential …

Background Domperidone may be used off‐label to increase breastmilk supply. In the
absence of manufacturer dosage recommendations, there is a need to compare the clinical …

Objective: Mothers of many preterm babies are unable to produce sufficient milk for their
babies during the prolonged hospitalization. Domperidone stimulates the release of …

Background The use of mother's own breast milk during initial hospitalization has a positive
impact not only in reducing potential serious neonatal morbidities but also contribute to …

Background: Insufficient milk supply is 1 of the most commonly reported reasons for
discontinuation of infant breastfeeding. Although domperidone is often used to improve milk …

Background: Domperidone is commonly used off-label to stimulate milk production in
mothers who have low milk supply. The aim of this study was to describe trends, patterns …

Objectives: To evaluate the efficacy and safety of domperidone and metoclopramide used by
breastfeeding women. Methods: A systematic literature search retrieved citations from …

BACKGROUND: Using mother's own expressed breast milk (EBM) has a positive impact in
reducing serious neonatal morbidities and improving neurodevelopmental outcomes for …

Mothers of hospitalized premature infants who choose to provide breast milk are at
increased risk of an inadequate breast milk supply. When nonpharmacologic interventions …